
Targeted intervention of melanoma by reprogramming...
Gender is an important factor in patients with melanoma. Female melanoma patients have an advantage over their male counterparts in terms of survival. However, the reason f...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Gender is an important factor in patients with melanoma. Female melanoma patients have an advantage over their male counterparts in terms of survival. However, the reason f...
In the U.S. alone during 2021, an estimated 106,110 and 101,280 people will be diagnosed with invasive and non-invasive (in situ) melanoma, respectively. Moreover, it is ex...
Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) grow out of control. It is more dangerous than most o...
Immunotherapy has fundamentally changed the way we treat melanoma patients. Checkpoint blockade specifically, which unleashes T cell killing of cancer cells, has extended p...
The major reason melanoma causes illness and death in patients is because the melanoma cells from the skin can travel to lymph nodes or into the blood which allows them to ...
Therapies that inhibit epigenetic modulators can induce a state of “virus mimicry” in cancer cells by activating long-overlooked “junk DNA” of the human genome. Thi...
A major obstacle to even the best melanoma therapies is that in the majority of cases, the tumor never completely goes away. Even if a little bit remains, called the minima...
Melanomas arise from pigmented cells called melanocytes, typically in the skin. Melanomas can spread to distal parts of the body, through a process called metastasis. Metas...
Melanoma is the third most common malignancy to metastasize to the brain. It is estimated that at least 50% of patients with stage IV melanoma will develop brain metastases...
Metastasis is the main cause of melanoma death. Current treatments mostly fail to cure metastasis. It is of common knowledge that disseminated cancer cells (DCCs)...
UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, the...
Cancer immunotherapy (CI) drugs activate our own immune system to directly kill cancer cells. These drugs have revolutionized how we treat many cancers including melanoma....
Oct 16, 2025 ET
Oct 30, 2025 ET